Opinion: Target the Vector

Officials’ increased emphasis on mosquito control could benefit public health efforts beyond the ongoing Zika outbreak.

Written byMirco Junker
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Aedes aegypti eggsWIKIMEDIA, CDCThe fast spread of Zika, which is now impacting nearly 50 countries on three continents, in combination with our limited understanding of the virus and infection-related symptoms and how the ongoing outbreak in Brazil might affect the upcoming Olympic Games in Rio, has garnered significant attention for this emerging pathogen. However, this recent attention on the Zika virus could wane quickly, particularly after the completion of the Olympic Games—which will justifiably not be cancelled or postponed due to the outbreak—and as a result of more positive news on the diagnostics and vaccine development fronts. Therefore, the public’s concerns regarding the Zika virus—including the corresponding pressure on politicians to provide reasonable funding to fight its spread—should be utilized to develop broader and more encompassing strategies to combat mosquito-borne diseases in general.

Although the Zika virus can have severe consequences for the affected individuals, the global impact of the Zika virus pales in comparison to that of other mosquito-borne diseases. With more than half a million deaths each year, mosquito-borne diseases such as malaria, dengue, and yellow fever still represent one of the 10 most common causes of morbidity and mortality in low-income countries, highlighting the need for a broad strategy incorporating the variety of mosquito-borne diseases as well as regional and local circumstances.

In particular, the focus on a Zika vaccine—although important—could result in a misplaced illusion of protection, thereby removing the required attention and future financial backing to combat mosquito-borne diseases.

The economic framework for the development, production, storage, and application of vaccines targeting mosquito-borne ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies